Abstract
More than ever before, health care providers are under intense pressure to control costs. Medical devices represent a significant ‘hard’ cost, with worldwide spending exceeding USD 235 billion. A growing number of health care providers are engaging in the practice of reprocessing—sterilizing and reusing medical devices labelled only for a single use. The ethical and technical dimensions of this practice have received much attention, but its economic aspects remain largely unexamined. This paper presents a Markov decision process framework that a health care provider can use to decide whether to use new or reprocessed devices in a given context. Two cases are studied: completely observable device condition and partially observable device condition. After briefly discussing structural results for the two cases, several examples are presented to illustrate how the model can be applied in practice. Useful results can be computed quickly with minimal data. A key insight of the model is that perfect information regarding the device condition is often not required to make a sound decision.
Similar content being viewed by others
References
Amid A, Ghodsypour SH and OBrien C (2006). Fuzzy multiobjective linear model for supplier selection in a supply chain. Int J Prod Econ 104: 394–407.
Bayazit O (2006). Use of analytic network process in vendor selection decisions. Benchmarking: Int J 13: 566–579.
Bennett P, Hare A and Townshend J (2005). Assessing the risk of vCJD transmission via surgery: Models for uncertainty and complexity. J Opl Res Soc 56: 202–213.
Brown SA, Merritt K, Woods TO, McNamee SG and Hitchins VM (2002). Effects of different disinfection and sterilization methods on tensile strength of materials used for single-use devices. Biomed Instrument Technol 36: 23–27.
Chen CT, Lin CT and Huang SF (2006). A fuzzy approach for supplier evaluation and selection in supply chain management. Int J Prod Econ 102: 289–301.
Chen KL, Chen KS and Li RK (2005). Suppliers capability and price analysis chart. Int J Prod Econ 98: 315–327.
Dunn D (2002). Reprocessing single-use devices—The ethical dilemma. AORN J 75: 989–999.
Fedel M, Tessarolo F, Ferrari P, Losche C, Ghassemieh N, Guarrera GM and Nollo G (2006). Functional properties and performance of new and reprocessed coronary angioplasty balloon catheters. J Biomed Mater Res Part B, Appl Biomater 78B: 364–372.
Fernández-Gaucherand E, Arapostathis A and Marcus SI (1991). On the average cost optimality equation and the structure of optimal policies for partially observable Markov decision processes. Ann Opns Res AC-29: 439–470.
Gottfried KL (2000). Are reprocessed medical devices really as good as new, and does it matter? HEC Forum 12: 311–316.
Haq AN and Kannan G (2006). Design of an integrated supplier selection and multi-echelon distribution inventory model in a built-to-order supply chain environment. Int J Prod Res 44: 1963–1985.
Harper PR and Pitt MA (2004). On the challenges of healthcare modelling and a proposed project life cycle for successful implementation. J Opl Res Soc 55: 657–661.
Heyman DP and Sobel MJ (1984). Stochastic Models in Operations Research, Volume II: Stochastic Optimization. McGraw-Hill: New York.
Hope J (2006). Cleared, surgeon who reused his tools to save cash. Daily Mail (London) 4 July, p 12.
Hopp WJ and Wu SC (1988). Multiaction maintenance under Markovian deterioration and incomplete state information. Nav Res Log 35: 447–462.
Hopp WJ and Wu SC (1990). Machine maintenance with multiple maintenance actions. IIE Trans 22: 226–232.
Hsu SP, Chuang DM and Arapostathis A (2006). On the existence of stationary optimal policies for partially observed MDPs under the long-run average cost criterion. Syst Control Lett 55: 165–173.
Ivy JS and Pollock SM (2005). Marginally monotonic maintenance policies for a multi-state deteriorating machine with probabilistic monitoring and silent failures. IEEE Trans Reliab 54: 489–497.
Jacobs P and Noorani H (2008). Re-use of single-use medical devices in Canada: Using evidence to inform policy. Proceedings of the 2008 CADTH Invitational Symposium. Canadian Agency for Drugs and Technologies in Health: Carling Avenue, Ottawa, Ontario, pp 600–865. http://cadth.ca/index.php/en/events/sympos-2008, accessed November 2008.
Kazaz B and Sloan T (2008). Production policies under deteriorating process conditions. IIE Trans 40: 187–205.
Kerber R (2005). Device makers fight reuse of surgical tools. Boston Globe, 19 October, p D.1.
Klein A (2005). Hospitals save money, but safety is questioned. Washington Post, 11 December, p A1.
Koh A and Kawahara K (2005). Current practices and problems in the reuse of single-use devices in Japan. J Med Dental Sci 52: 81–89.
Landro L (2008). The informed patient: Hospitals reuse medical devices to lower costs. Wall Street Journal, 19 March, p D.1.
Linn RJ, Tsung F and Ellis LWC (2006). Supplier selection based on process capability and price analysis. Qual Eng 18: 123–129.
Mak KH, Eisenberg MJ, Eccleston DS, Brown KJ, Ellis SG and Topol EJ (1996). Cost-efficacy modeling of catheter reuse for percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 28: 106–111.
Makis V and Jiang X (2003). Optimal replacement under partial observations. Math Opns Res 28: 382–394.
MEDEC (2004). The reuse of single use medical devices. Technical Report. MEDEC: Canada's Medical Device Technology Companies, Toronto, Canada.
Monahan G (1982). A survey of partially observable Markov decision processes: Theory, models, and algorithms. Mngt Sci 28: 1–16.
Roth K, Heeg P and RR (2002). Specific hygiene issues relating to reprocessing and reuse of single-use devices for laparoscopic surgery. Surg Endoscop 16: 1091–1097.
Sloan T (2007). Safety-cost trade-offs in medical device reuse: A Markov decision process model. Health Care Mngt Sci 10: 81–93.
Sloan T (2008). First do no harm? A framework for evaluating new vs. reprocessed medical devices. Working Paper. University of Massachusetts Lowell: Lowell, MA.
Standard & Poor's (2007). Healthcare: Products and supplies. Standard & Poor's Ind Surv 175: 14–15.
Su CT, Wu SC and Chang CC (2000). Multiaction maintenance subject to action-dependent risk and stochastic failure. Eur J Opl Res 125: 133–148.
Tessarolo F, Caola I, Nollo G, Antolini R, Guarrera GM and Caciagli P (2006). Efficiency in endotoxin removal by a reprocessing protocol for electrophysiology catheters based on hydrogen peroxide plasma sterilization. Int J Hygiene Environment Health 209: 557–565.
Tessarolo F, Caola I, Fedel M, Stacchiotti A, Caciagli P, Guarrera GM, Motta A and Nollo G (2007). Different experimental protocols for decontamination affect the cleaning of medical devices: Preliminary electron microscopy analysis. J Hosp Infect 65: 326–333.
Wang EP (2001). Regulatory and legal implications of reprocessing and reuse of single-use medical devices. Food Drug Law J 56: 77–98.
Wang H (2002). A survey of maintenance policies of deteriorating systems. Eur J Opl Res 139: 469–489.
White CC (1979). Optimal control-limit strategies for a partially observed replacement problem. Int J Syst Sci 10: 321–331.
Xia W and Wu Z (2007). Supplier selection with multiple criteria in volume discount environments. Omega 35: 494–504.
Yang CC and Chen BS (2006). Supplier selection using combined analytical hierarchy process and grey relational analysis. J Manuf Technol Mngt 17: 926–941.
Author information
Authors and Affiliations
Corresponding author
Appendices
Appendix A. Main technical results
The main technical results of the model are summarized here. For more details and for proofs, please refer to Sloan (2008).
A.1. COMDP: indifference points
Proposition A.1
-
With respect to the repair probability of a used device (p10u), comparing policies A1=[r,n,n,n] and A2=[r,u,n,n] yields the following indifference point:
When p10u>ρ1*(A1,A2), using a refurbished device is optimal in state 1; when p10u<ρ1*(A1,A2), using a new device is optimal in state 1.
Proposition A.2
-
With respect to the repair probability of a used device (p20u), comparing policies A2=[r,u,n,n] and A3=[r,u,u,n] yields the following indifference point:
When p20u>ρ2*(A2,A3), using a refurbished device is optimal in state 2; when p20u<ρ2*(A2,A3), using a new device is optimal in state 2.
A.2. COMDP: monotonicity conditions
In this context, one condition is sufficient to ensure the monotonicity of the optimal policy: as the condition of a used device gets worse, the likelihood of returning it to like-new condition is non-increasing. In other words, as long as the repair probability does not increase as the state gets worse, the optimal policy will call for increasingly effective (and costly) maintenance actions. The next proposition formalizes this intuitive result.
Proposition A.3
-
If pi0u⩾pj0u for each j>i, then the optimal policy will be monotone with respect to the process state.
A.3. POMDP: existence of an optimal policy
Proposition A.4
-
A bounded solution to Equation (5) exists, and a unique, stationary policy exists that minimizes the average expected cost. Furthermore, the average cost per unit time is constant; that is, g(α)=g*, independent of the initial belief vector.
The result follows direction from Theorem 4.2 of Fernández-Gaucherand et al (1991).
Appendix B. Data for example problems
Most of the data used for the example problems are reported in Section 4. This section reports all of the remaining data necessary to solve the problem variants discussed. Cost data are based on numbers from Klein (2005) and Landro (2008) unless otherwise noted.
B.1. Post-procedure observation probabilities
Table B1 reports the post-procedure observation probabilities, q jk r, used for in the example problems. By definition, a device cannot be in state 0 (perfect condition) after a procedure is performed, so corresponding observation probabilities are not relevant. In addition, the probability of observing state 0 after a procedure is performed is 0.
B.2. Post-reprocessing observation probabilities
For all example problems, a Very High information quality level refers to the following observation probabilities:
where j (row) is the observed state and k (column) is the actual state.
B.3. Parameters for example 1: angioplasty balloon
Costs and rewards: N=515, U=250, C=1 000 000, R=−16 000.
Transition probabilities:
B.4. Parameters for example 2: pulse oximetry sensor
Costs and rewards: N=10, U=6, C=10 000, R=−15.
Transition probabilities:
B.5. Parameters for example 3: orthopaedic blade
Costs and rewards: N=30, U=15, C=100 000, R=−650.
Transition probabilities:
B.6. Parameters for example 4: laparoscopic surgery
Costs and rewards: N=1200, U=250, C=1 000 000, R=−8000.
Transition probabilities:
Rights and permissions
About this article
Cite this article
Sloan, T. First, do no harm? A framework for evaluating new versus reprocessed medical devices. J Oper Res Soc 61, 191–201 (2010). https://doi.org/10.1057/jors.2008.137
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1057/jors.2008.137